Clinical Trials for Kartos Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kartos Therapeutics

Clinical Trials (6)

NCT06479135
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
PHASE3Recruiting
600 participants
Started: Jun 3, 2024 · Completed: Dec 31, 2028
5 conditions1 sponsor215 locations
NCT05797831
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
PHASE2/PHASE3Recruiting
268 participants
Started: Jul 17, 2023 · Completed: Jul 31, 2027
1 condition3 sponsors83 locations
NCT04835584
KRT-232 and TKI Study in Chronic Myeloid Leukemia
PHASE1/PHASE2Recruiting
109 participants
Started: May 7, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor26 locations
NCT04878003
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
PHASE2Recruiting
52 participants
Started: Apr 13, 2021 · Completed: Oct 31, 2025
3 conditions1 sponsor29 locations
NCT04669067
TL-895 and KRT-232 Study in Acute Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
18 participants
Started: Mar 31, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors35 locations
NCT03662126
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
PHASE2/PHASE3Recruiting
385 participants
Started: Jan 15, 2019 · Completed: Dec 31, 2025
3 conditions1 sponsor191 locations